Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-24-016513
Filing Date
2024-02-23
Accepted
2024-02-23 16:18:59
Documents
6
Effectiveness Date
2024-02-23

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0200445-s8_citiusphar.htm S-8 113401
2 OPINION OF WYRICK ROBBINS YATES & PONTON LLP ea0200445ex5-1_citiusphar.htm EX-5.1 6335
3 CONSENT OF WOLF & COMPANY, P.C ea0200445ex23-1_citiusphar.htm EX-23.1 1713
4 LEONARD-MERON BIOSCIENCES, INC. 2013 STOCK PLAN ea0200445ex99-1_citiusphar.htm EX-99.1 73083
5 FORM OF NOTICE OF STOCK OPTION GRANT AND STOCK OPTION AWARD AGREEMENT UNDER LEON ea0200445ex99-2_citiusphar.htm EX-99.2 75651
6 FILING FEE TABLE ea0200445ex-fee_citiusphar.htm EX-FILING FEES 13191
  Complete submission text file 0001213900-24-016513.txt   284619
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-277315 | Film No.: 24671484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)